Patel Sanjiv 4
4 · Relay Therapeutics, Inc. · Filed Nov 4, 2025
Insider Transaction Report
Form 4
Patel Sanjiv
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2025-11-03$7.00/sh−62,073$434,511→ 703,215 total
Holdings
- 687,355(indirect: By Trust)
Common Stock
- 199,548(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 136,853 shares of restricted stock units ("RSUs") on October 31, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
- [F2]Includes 136,854 shares underlying RSUs.
- [F3]These shares are held in irrevocable trusts for the benefit of the reporting person's family members. An independent trustee is trustee of the trusts. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.